Results 171 to 180 of about 203,299 (265)

Early Detection of Ductal Carcinoma in situ through Surveillance in a Patient with Peutz-Jeghers Syndrome: A Case Report. [PDF]

Case Rep Oncol
Murakami F, Uomori T, Kutomi G, Arai M.
europepmc   +1 more source

Pattern of Progression of Oral Potentially Malignant Disorders From Real‐World Data: A 24‐Year Study

Head &Neck, EarlyView.
ABSTRACT Background Oral potentially malignant disorder (OPMD) prognostication is limited by uncertainty of which lesions will progress and the aggressiveness of lesion progression. We defined patterns and kinetics of progression in a large cohort of OPMD subjected to serial clinical and histologic examinations. Methods This 24‐year study evaluated the
Subin Surendran, Sumsum P. Sunny, Preethi M. Chathoth, William J. Magner, S. Lynn Sigurdson, Mihai Merzianu, Norbert Sule, Anurag K. Singh, Kimberly E. Wooten, Ryan P. McSpadden, Vishal Gupta, Amritha Suresh, Ashok Z. Samuel, Rohit Bhargava, Praveen N. Birur, Wesley L. Hicks Jr, Moni Abraham Kuriakose   +16 more
wiley   +1 more source

Overdiagnosis of ductal carcinoma in situ by grade and definition in population-based screening: A modeling study. [PDF]

Breast
Poelhekken K, Greuter MJW, van der Vegt B, Dorrius MD, de Bock GH.   +4 more
europepmc   +1 more source

In Situ Carcinoma [PDF]

, 2011
openaire   +1 more source

Limitations of photodynamic therapy in HPV-positive Erythroplasia of Queyrat: A case of progression to carcinoma in situ. [PDF]

Medicine (Baltimore)
Lou Y, Duan Q, Yang L, Zhou P.
europepmc   +1 more source

FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ. [PDF]

Cancer Cytopathol
Ye J, Goldhammer N, Vohra P, Warhadpande S, de Castro GC, Rodas CKM, Moasser MM, Ramalingam K, Abe SE, Alvarado M, Ewing C, Goodwin KM, Mukhtar RA, Wong JM, Esserman LJ, Balassanian R, Rosenbluth JM.   +16 more
europepmc   +1 more source

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

International Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin, Venugopalareddy Mekala, Jianrong Li, Xiang Wang, Muhammad Aminu, Jia Wu, Jianjun Zhang, Robert Taylor Ripley, Christopher I. Amos, Chao Cheng   +9 more
wiley   +1 more source

FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ. [PDF]

Clin Cancer Res
Heiss BL, Chang E, Joeng HK, Fiero MH, Wang L, Hamed SS, Chiu HJ, Ricks TK, Koh EH, Dellibovi-Ragheb TA, Wang M, Lee C, Pierce WF, Leighton JK, Rahman NA, Tang S, Pazdur R, Amiri-Kordestani L, Kluetz PG, Suzman DL.   +19 more
europepmc   +1 more source